A massive fire broke out at Terminal 1 gate of Serum Institute of India in Pune on Thursday afternoon. The incident claimed 5 lives. Ten fire tenders and a team of the National Disaster Response Force (NDRF) were rushed to the spot to douse the fire that broke out around 2.45 pm. The cause of the fire at the Serum Institute plant is not yet known. Watch the video for more details.Also Read: Fire breaks out at Serum Institute of India's plant in Pune, Covishield production not hit

A massive fire broke out at Terminal 1 gate of Serum Institute of India in Pune on Thursday afternoon. The blaze was reported at an under-construction building in the Manjri area of the city. The SII plant is spread over 100 acres in Pune. Visuals showed large plumes of smoke billowing out of the buildings. As per initial reports, eight fire tenders were rushed to the fire spot.

PM Modi criticises previous govts, says the poor had to bear for their 'wrong' policies and intentions

It is learnt that 1,50,000 doses of Covisheild vaccine, manufactured by the Serum Institute of India (SII), were sent to Bhutan and 1,00,000 doses reached Maldives as part of India's grant assistance

In the first phase, which started from January 13, the airline transported a total of 7,20,000 doses to five destinations.

On Tuesday, 112 people tested positive for infection in state; caseload rises to 52,570

The number of people who have recuperated from the disease surged to 1,02,28,753, pushing the national COVID-19 recovery rate to 96.66 per cent

Due to winter surge in US, coronavirus deaths are rising, overall toll toward 400,000 , warning of a new variant in states

According to a statement issued by the department, 18,122 \"corona warriors\" had been vaccinated on the inaugural day, while 14,745 received the jabs on Monday

IT services major Wipro said it had completed its Rs 9,500-crore share buyback programme; Amazon Prime Video is focusing its investments on bringing more content and expanding its service to a larger audience in India; A parliamentary panel has summoned representatives of Facebook and Twitter to appear before it on January 21. Watch this and more on News Blast.Also Read: Mukesh Ambani's JioMart to be available on WhatsApp in next six months

Our finding that smokers are less likely to be seropositive is the first report from the general population and part of growing evidence that despite COVID-19 being a respiratory disease, smoking may be protective, CSIR said

Police are also probing if other officials helped Gawande to get the bribes as well as the number of flyers he cleared with fake document

With eight different coronavirus spike fragments, the scientists said this vaccine platform can generate a diverse antibody response -- an advantage over traditional vaccine methods that present pieces from only a single type of virus

The insurers should make efforts to have agreement with health providers on rates for treatment of Covid-19 similar to other diseases for which rate agreements are in place, IRDAI said

The first consignment of Covishield vaccine, having rolled out of the Serum Institute of India in Pune, reached Delhi, Chennai and Ahmedabad. The nation is getting ready for a massive pan-India inoculation drive against COVID-19, starting January 16. Four airlines were authorised to operate nine flights, to transport 56.5 lakh doses of the vaccine from Pune to 13 cities across the country. Three crore healthcare and frontline workers will be vaccinated in the first phase of the drive. Watch the video for more.Also Read: Four more COVID-19 vaccines on cards in India, check prices here

Coronavirus vaccine: A royal source said the vaccines were administered by a household doctor at the queen's Windsor Castle residence, adding that she made the news public to counter any speculation

16th Pravasi Bharatiya Divas convention: in the midst of these challenges, the way Indian-origin colleagues across the world have worked, have done their duty, it is a matter of pride for all of us, said PM Modi

Coronavirus pandemic: Without the uniform implementation of effective face masking and strict social distancing, epidemics could quickly worsen as these variants spread and become predominant, said the task force

Critics have said that the country's immunisation campaign is running behind its regional peers and have questioned why the government has not moved more swiftly

Bharat Biotech has sent a proposal to the Drugs Controller General of India (DCGI) to seek its approval for trials of a nasal vaccine against COVID-19. The firm recently introduced Covaxin vaccine in India, which has been approved for emergency use in the country. The trials for nasal vaccine will be conducted on at least 30-45 volunteers above the age of 18 years at four trial sites in the country, including Bhubaneswar, Pune, Nagpur and Hyderabad. Watch the video for more.Also Read: Phase 1 vaccination to cost govt Rs 21,000-27,000 crore: SBI Research